Abstract:We designed a novel heterocyclic‐substituted 4,5‐dihydropyrazole derivative, MW‐19. MW‐19 exhibited potential antitumor activity, both in vitro and in vivo, and induced HCC‐1806 cell apoptosis. Importantly, blockade of P38 using a pharmacological inhibitor (SB20358) abrogated MW‐19‐induced apoptosis, suggesting that MW‐19 activates the apoptotic P38 MAPK signaling pathway. These findings provide a scientific foundation for the potential development of MW‐19 for treatment of triple‐negative breast cancer. Previous studies have indicated that heterocyclic substituted dihydropyrazole derivatives, particularly MW‐19, potentially exert anticancer activity in vitro; however, the underlying mechanism remains unknown. The present study was designed to investigate the mechanisms underlying MW‐19 activity in triple‐negative breast cancer cells. A sulforhodamine B assay was performed to evaluate cell proliferation inhibition rates, and the antitumor effect of MW‐19 was evaluated in mice with HCC‐1806 xenografts. Apoptosis was analyzed by Hoechst 33342 and annexin V/propidium iodide staining. Expression of pro‐ and antiapoptotic proteins and mRNA were analyzed by western blotting and reverse transcription‐quantitative (RT‐q) PCR, respectively. We found that MW‐19 significantly inhibited HCC‐1806 cell proliferation in a dose‐ and time‐dependent manner, and significantly inhibited MDA‐MB‐231 cell migration. Importantly, oral administration of MW‐19 significantly inhibited HCC‐1806 tumor growth in BALB/c‐nu/nu mice. Moreover, MW‐19 treatment induced marked apoptosis and G2/M arrest in the sensitive cell line, HCC‐1806. RT‐qPCR analysis showed that levels of proapoptotic genes (Bax, caspase‐3, caspase‐7, and Fas) were considerably increased in the MW‐19 group relative to the control group, while those of antiapoptotic factors (Bcl‐2, C‐MYC) were dramatically decreased. Consistently, Bax, caspase‐3, and caspase‐7 were significantly induced after MW‐19 treatment, while levels of phosphorylated (p‐)AKT, p‐PI3K, p‐ERK, and the antiapoptotic protein, Bcl‐2, were clearly diminished, and the P38 MAPK signaling pathway was activated. Furthermore, P38 pharmacological inhibitors abrogated MW‐19‐induced apoptosis. Together, our findings indicate that MW‐19 exerts antitumor effects by targeting PI3K/AKT and ERK/P38 signaling pathways.

LW-214, a Newly Synthesized Flavonoid, Induces Intrinsic Apoptosis Pathway by Down-Regulating Trx-1 in MCF-7 Human Breast Cells

LW-213, a derivative of wogonin, triggers reticulophagy-mediated cell death in NSCLC via lysosomal damage combined with NPC1 inhibition

LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK–eIF2α–ATF4–CHOP axis

Cryptotanshinone inhibits proliferation and induces apoptosis via mitochondria-derived reactive oxygen species involving FOXO1 in estrogen receptor-negative breast cancer Bcap37 cells

LW-213, a Newly Synthesized Flavonoid, Induces G2/M Phase Arrest and Apoptosis in Chronic Myeloid Leukemia

Luteolin Inhibits Nrf2 Leading to Negative Regulation of the Nrf2/Are Pathway and Sensitization of Human Lung Carcinoma A549 Cells to Therapeutic Drugs

Atractylodin induces oxidative stress‐mediated apoptosis and autophagy in human breast cancer MCF‐7 cells through inhibition of the P13K/Akt/mTOR pathway

MW‐19, a dihydropyrazole derivative, induces human triple‐negative breast cancer cell apoptosis by targeting apoptosis‐related pathways

The Flavones Induce Breast Cancer Cell Apoptosis Via Activation Foxo3a

Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway

The Flavonoid TL-2-8 Induces Cell Death and Immature Mitophagy in Breast Cancer Cells Via Abrogating the Function of the AHA1/Hsp90 Complex.

LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells

Mitochondrial Dysfunction As an Early Event in the Process of Apoptosis Induced by Woodfordin I in Human Leukemia K562 Cells

Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins

Quercetin-induced Apoptosis Acts Through Mitochondrial- and Caspase-3-dependent Pathways in Human Breast Cancer MDA-MB-231 Cells

A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products

SZC017, a novel oleanolic acid derivative, induces apoptosis and autophagy in human breast cancer cells

Inhibition of cancer growth in vitro and in vivo by a novel ROS-modulating agent with ability to eliminate stem-like cancer cells

Resveratrol Induces Apoptosis in Breast Cancer Cells by E2f1-Mediated Up-Regulation of Aspp1

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

A New Flavanone from Chromolaena tacotana (Klatt) R. M. King and H. Rob, Promotes Apoptosis in Human Breast Cancer Cells by Downregulating Antiapoptotic Proteins